140 related articles for article (PubMed ID: 9767292)
1. The effect of long-term treatment with tacalcitol on the psoriatic epidermis. A flow cytometric analysis.
Mommers JM; Castelijns FA; Seegers BA; Van Rossum MM; Van Hooijdonk CA; Van Erp PE; Van De Kerkhof PC
Br J Dermatol; 1998 Sep; 139(3):468-71. PubMed ID: 9767292
[TBL] [Abstract][Full Text] [Related]
2. Topical treatment of psoriatic plaques with 1 alpha, 24 dihydroxyvitamin D3: a multiparameter flow cytometrical analysis of epidermal growth, differentiation and inflammation.
Glade CP; van Erp PE; van Hooijdonk CA; Elbers ME; van de Kerkhof PC
Acta Derm Venereol; 1995 Sep; 75(5):381-5. PubMed ID: 8615058
[TBL] [Abstract][Full Text] [Related]
3. Reduction of epidermal abnormalities and inflammatory changes in psoriatic plaques during treatment with vitamin D3 analogs.
van de Kerkhof PC
J Investig Dermatol Symp Proc; 1996 Apr; 1(1):78-81. PubMed ID: 9627698
[TBL] [Abstract][Full Text] [Related]
4. Influence of tacalcitol on cell cycle kinetics of human keratinocytes following standardized injury.
Mommers JM; ter Meulen AC; van Erp PE; van de Kerkhof PC
Skin Pharmacol Appl Skin Physiol; 1999; 12(4):174-81. PubMed ID: 10420137
[TBL] [Abstract][Full Text] [Related]
5. Tacalcitol in the treatment of psoriasis vulgaris: the Spanish experience.
Lecha M; Mirada A; López S; Artés M;
J Eur Acad Dermatol Venereol; 2005 Jul; 19(4):414-7. PubMed ID: 15987284
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological profiles of high-concentration (20 microg/g) tacalcitol ointment: effects on cutaneous inflammation, epidermal proliferation, and differentiation in mice.
Sato H; Ogino Y; Takagi H; Hata J; Asano S; Ohta T; Komoriya K
J Dermatol; 2003 Jul; 30(7):510-24. PubMed ID: 12928540
[TBL] [Abstract][Full Text] [Related]
7. Tacalcitol (1,24(OH)2D3, TV-02) inhibits phorbol ester-induced epidermal proliferation and cutaneous inflammation, and induces epidermal differentiation in mice.
Sato H; Sugimoto I; Matsunaga T; Tsuchimoto M; Ohta T; Uno H; Kiyoki M
Arch Dermatol Res; 1996 Oct; 288(11):656-63. PubMed ID: 8931867
[TBL] [Abstract][Full Text] [Related]
8. Multiparameter flow cytometry as a tool to evaluate antipsoriatic therapy.
Glade CP; van Erp PE; Boezeman JB; van de Kerkhof PC
Br J Dermatol; 1997 Sep; 137(3):367-75. PubMed ID: 9349331
[TBL] [Abstract][Full Text] [Related]
9. The effect of tacalcitol (1,24(OH)2D3) on cutaneous inflammation, epidermal proliferation and keratinization in psoriasis: a placebo-controlled, double-blind study.
Gerritsen MJ; Boezeman JB; van Vlijmen-Willems IM; Van de Kerkhof PC
Br J Dermatol; 1994 Jul; 131(1):57-63. PubMed ID: 7519032
[TBL] [Abstract][Full Text] [Related]
10. Proliferation is the main epidermal target in the treatment of psoriatic plaques with once daily application of tacalcitol ointment.
Castelijns FA; Gerritsen MJ; van Vlijmen-Willems IM; van Erp PJ; van de Kerkhof PC
Acta Derm Venereol; 1999 Mar; 79(2):111-4. PubMed ID: 10228627
[TBL] [Abstract][Full Text] [Related]
11. Transglutaminase-positive cells in psoriatic epidermis during treatment with calcitriol (1alpha,25 dihydroxy vitamin D3) and tacalcitol (1alpha,24 dihydroxy vitamin D3).
Gerritsen MJ; van Erp PE; van de Kerkhof PC
Br J Dermatol; 1995 Oct; 133(4):656-9. PubMed ID: 7577606
[No Abstract] [Full Text] [Related]
12. A multiparameter flow cytometric analysis of the effect of bexarotene on the epidermis of the psoriatic lesion.
Franssen ME; Smit JV; Van Erp PE; Van De Kerkhof PC
Br J Dermatol; 2003 Sep; 149(3):506-12. PubMed ID: 14510982
[TBL] [Abstract][Full Text] [Related]
13. Novel functional multiparameter flow cytometric assay to characterize proliferation in skin.
Mommers JM; Goossen JW; van De Kerkhof PC; van Erp PE
Cytometry; 2000 Feb; 42(1):43-9. PubMed ID: 10679742
[TBL] [Abstract][Full Text] [Related]
14. [Treatment of scalp psoriasis. An effective and safe tacalcitol emulsion].
Ruzicka T; Trompke C
Hautarzt; 2004 Feb; 55(2):165-70. PubMed ID: 14968327
[TBL] [Abstract][Full Text] [Related]
15. A comparison of psoralen plus ultraviolet A (PUVA) monotherapy, tacalcitol plus PUVA and tazarotene plus PUVA in patients with chronic plaque-type psoriasis.
Tzaneva S; Hönigsmann H; Tanew A; Seeber A
Br J Dermatol; 2002 Oct; 147(4):748-53. PubMed ID: 12366423
[TBL] [Abstract][Full Text] [Related]
16. Long-term safety and efficacy of high-concentration (20 microg/g) tacalcitol ointment in psoriasis vulgaris.
Miyachi Y; Ohkawara A; Ohkido M; Harada S; Tamaki K; Nakagawa H; Hori Y; Nishiyama S
Eur J Dermatol; 2002; 12(5):463-8. PubMed ID: 12370136
[TBL] [Abstract][Full Text] [Related]
17. An update on vitamin D3 analogues in the treatment of psoriasis.
van de Kerkhof PC
Skin Pharmacol Appl Skin Physiol; 1998; 11(1):2-10. PubMed ID: 9603664
[TBL] [Abstract][Full Text] [Related]
18. Long-term efficacy and safety of tacalcitol ointment in patients with chronic plaque psoriasis.
van de Kerkhof PC; Berth-Jones J; Griffiths CE; Harrison PV; Hönigsmann H; Marks R; Roelandts R; Schöpf E; Trompke C
Br J Dermatol; 2002 Mar; 146(3):414-22. PubMed ID: 11952541
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of high-concentration tacalcitol ointment in psoriasis vulgaris after changing from other high-concentration vitamin D3 ointments.
Syuto T; Ishibuchi H; Sogabe Y; Yokoyama Y; Ishikawa O
Dermatol Online J; 2008 Feb; 14(2):2. PubMed ID: 18700105
[TBL] [Abstract][Full Text] [Related]
20. Epidermal cell DNA content and intermediate filaments keratin 10 and vimentin after treatment of psoriasis with calcipotriol cream once daily, twice daily and in combination with clobetasone 17-butyrate cream or betamethasone 17-valerate cream: a comparative flow cytometric study.
Glade CP; Van Erp PE; Van De Kerkhof PC
Br J Dermatol; 1996 Sep; 135(3):379-84. PubMed ID: 8949429
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
